Document:OpenLetterToGSK.pdf

From AIDS Wiki

This is the document namespace holder page for the PDF document file OpenLetterToGSK.pdf, located on AIDS Wiki servers. This PDF file is NOT available under the GNU Free Documentation License.

Open letter from Anthony Brink to John Kearney, CEO of GlaxoSmithKline, South Africa, dated 26 April 2001.

"You allege in the package insert supplied with AZT that it's converted by enzymes inside human cells from its parent form as a pro-drug into its active agent, AZT triphosphate. And that AZT triphosphate stops HIV replication by being incorporated into growing proviral DNA chains during reverse transcription of HIV RNA. But neither of these claims is true and your company knows it."

(6 pages)

NOTWITHSTANDING ANY OTHER NOTICE ON THIS PAGE, the material on this page is NOT available under the GNU Free Documentation License; in accordance with Title 17 U.S.C. section 107, it is posted in the manner of bulletin boards in schools and workplaces, to encourage public education and citizen awareness, without profit or payment, for persons and entities engaging in non-profit research and educational activities and purposes only.